Venture capital for companies developing innovative therapeutics

Our Team

We are driven by the quest for new and better medicines.

Innovative Drug Development

Be invested in an attractive growth market.

BB Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats.

BB Pureos Bioventures strives to impact patients’ lives by advancing innovative treatments for severe diseases.

We are driven by the quest for new and better medicines

Our Portfolio

Our companies develop innovative medicines.

Latest News

We are happy to share our latest progress.

January 2021

Narrow River Management announces formation and financing of two new companies developing therapies for renal diseases

November 2020

AM-Pharma Announces Enrollment of the First Patient in REVIVAL Phase III Pivotal Trial in Patients with Sepsis-Associated Acute Kidney Injury

Member of